Evidence map›Paper›PMID 38434676›Full record

ReviewApplied physics reviews2024

Mechanical forces amplify TCR mechanotransduction in T cell activation and function.

Nicholas Jeffreys, Joshua M Brockman, Yunhao Zhai, Donald E Ingber, David J Mooney

Open access · bronzeAbstract readReview
In one paragraph

Review in Applied physics reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. PIEZO1 in Immune Cells: From Force to Function.Results and problems in cell differentiation · 2026
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. The Rise of Mechanobiology for Advanced Cell Engineering and Manufacturing.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yunhao ZhaiWyss Institute for Biologically Inspired Engineering, Boston, Massachusetts 02115, USA.ORCID https://orcid.org/0000-0002-7826-217X
Harvard University · USBoston Children's Hospital · US

Funding

Th1 polarizing immune responses using DNA origamiU54CA244726 · NCI · HARVARD UNIVERSITY · PI HODI, FRANK S, MOONEY, DAVID J · 2019 to 2019
$8.2M
NCI NIH HHS U54 CA244726Wellcome Trust
6 · The paper itself

Abstract

Adoptive T cell immunotherapies, including engineered T cell receptor (eTCR) and chimeric antigen receptor (CAR) T cell immunotherapies, have shown efficacy in treating a subset of hematologic malignancies, exhibit promise in solid tumors, and have many other potential applications, such as in fibrosis, autoimmunity, and regenerative medicine. While immunoengineering has focused on designing biomaterials to present biochemical cues to manipulate T cells

Identifiers

PMID38434676
PMCPMC10848667
OpenAlexW4391024983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.